Belgium· BE-AMP-SAM271467-00
Arteoptic LA 1 %
A carteolol product containing carteolol hydrochloride, registered in Belgium by Bausch & Lomb Pharma. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Carteolol is registered in 8 of 19 countries.
Countries holding a registration under ATC S01ED05 (carteolol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Carteolol · ATC S01ED05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Carteolol Hydrochloride
- Manufacturer
- Bausch & Lomb Pharma
- Country
- Belgium (BE)
- ATC code
- S01ED05
- ATC class
- Carteolol
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2244895
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
97 interactions on record for carteolol.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carteolol · interactions on record
97 records
- 28 severe
- 67 moderate
- 2 minor
Most severe, free to view
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- TheophyllinC01EB28severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carteolol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsDowelhurst Ltd
- Japanカルテオロール塩酸塩東亜薬品
- ItalyCARTEABAK*collirio 5 ml 1%LABORATOIRES THEA
- FranceCARTEOL 1 %, collyre en solutionLABORATOIRE CHAUVIN
- SpainARTEOPTIC 1% COLIRIO DE LIBERACION PROLONGADABausch + Lomb Ireland Limited
- PolandCarteol LP 2%Medezin Sp. z o.o.
- SwitzerlandArteoptic LA
- CzechiaCARTEOL LPDr. Gerhard Mann, Chem.- pharm. Fabrik GmbH, Berlín
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Czechia · Carteol Lp, Carteol Neo
- Spain · Arteoptic, Arteoptic Pf
- France · Carteol, Carteol L.P.
- Croatia · Cartelomb
- Italy · Carteabak, Carteol
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c724b0c8-374c-46e1-9bc6-8aa50a75a3a5 GET /v1/drugs/c724b0c8-374c-46e1-9bc6-8aa50a75a3a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, prolonged-release",
"source": "afmps",
"status": "REVOKED",
"name_en": "Arteoptic LA 1 %",
"name_fr": "Arteoptic LA 1 %",
"name_nl": "Arteoptic LA 1 %",
"amp_code": "SAM271467-00",
"strengths": [
"10.0000"
],
"pack_count": 1,
"substances": [
"Carteolol Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Carteolol",
"authorisation_numbers": [
"BE271467"
]
}See everything about carteolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.